-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Sandhya Pruthi, MD, an internist at the Mayo Clinic and author of the review, said that it is prudent for health care providers to understand the benefits of assessing individual breast cancer risk, and to counsel patients and implement risk reduction strategies
.
Dr.
Pruthi said that evidence-based risk reduction strategies include life>
.
Women with a high risk of hereditary breast cancer mutations should consider preventive surgery to reduce the risk
Dr.
Pruthi said: “Doctors should recommend individualized risk assessments for patients and advise them to take interventions, from life>
.
”
She said these strategies may help reduce hormone-sensitive breast cancer tumors with good prognosis, and may also help prevent hormone-insensitive, poor prognostic tumors
.
"For many years, breast cancer prevention research has mainly focused on the use of anti-estrogen drugs to reduce the incidence of favorable, hormone-sensitive breast cancer.
However, we re-examine and implement other risk-reducing strategies to prevent unfavorable breast cancer.
Negative tumors, this is crucial
.
" Dr.
She encouraged women and their health care providers to consider a comprehensive approach to breast cancer prevention, including risk assessment; recognizing changeable life>
.
Dr.
Pruthi said that her review is based on studies conducted in two large randomized clinical trials: the Women’s Health Initiative Diet Adjustment Trial and the Women’s Health Initiative Randomized Trial, which uses conjugated equine estrogens in women with a history of hysterectomy
.
She said that these two clinical trials have demonstrated a reduction in breast cancer mortality
Journal Reference :
Sandhya Pruthi, Dawn M.
